Charles Baker-Glenn,Mark Chambers,Bryan K. Chan,Anthony Estrada,Zachary Kevin Sweeney
申请号：
US13687421
公开号：
US08791130B2
申请日:
2012.11.28
申请国别(地区):
US
年份:
2014
代理人:
摘要：
Compounds of the formula I:or pharmaceutically acceptable salts thereof,wherein m, n. X, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
